Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Intentional product use issue? 2,037 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,037 reports of Intentional product use issue have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.6% of all adverse event reports for LENALIDOMIDE.

2,037
Reports of Intentional product use issue with LENALIDOMIDE
0.6%
of all LENALIDOMIDE reports
205
Deaths
255
Hospitalizations

How Dangerous Is Intentional product use issue From LENALIDOMIDE?

Of the 2,037 reports, 205 (10.1%) resulted in death, 255 (12.5%) required hospitalization, and 25 (1.2%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 2,037 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which LENALIDOMIDE Alternatives Have Lower Intentional product use issue Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue LENALIDOMIDE Demographics